ANISH BHATNAGAR (President and CEO) sold 12.9% of their position (127.34K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $5.81M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 8/7/2024ACC: 0001415889-24-020943
DirectorOfficer· President and CEO
Since Jan 2019
-127.34K
Net shares
Net seller
$5.81M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
127.34K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−32.79K
Price / share
$45.48
Trade value
$1.49M
% of position
3.3%
8/5/2024
983.53K→950.75K
Common Stock
Direct
Shares
−25.42K
Price / share
$46.14
Trade value
$1.17M
% of position
2.7%
8/5/2024
950.75K→925.32K
Common Stock
Direct
Shares
−6.79K
Price / share
$43.64
Trade value
$296.27K
% of position
0.7%
8/6/2024
925.32K→918.53K
Common Stock
Direct
Shares
−22.94K
Price / share
$45.25
Trade value
$1.04M
% of position
2.5%
8/6/2024
918.53K→895.60K
Common Stock
Direct
Shares
−39.41K
Price / share
$45.89
Trade value
$1.81M
% of position
4.4%
8/6/2024
895.60K→856.19K
Total
Net shares
−127.34K
Net value
-$5.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/5/2024 | S · Sale | −32.79K | $45.48 | $1.49M | 3.3% | 983.53K | 950.75K |
| Common Stock Direct | 8/5/2024 | S · Sale | −25.42K | $46.14 | $1.17M | 2.7% | 950.75K | 925.32K |
| Common Stock Direct | 8/6/2024 | S · Sale | −6.79K | $43.64 | $296.27K | 0.7% | 925.32K | 918.53K |
| Common Stock Direct | 8/6/2024 | S · Sale | −22.94K | $45.25 | $1.04M | 2.5% | 918.53K | 895.60K |
| Common Stock Direct | 8/6/2024 | S · Sale | −39.41K | $45.89 | $1.81M | 4.4% | 895.60K | 856.19K |
| Total | −127.34K | -$5.81M | ||||||
Derivative Transactions0
No derivative transactions reported